Cancer care cost trends in the United States: 1998 to 2012

Cancer

Volumn 122, Issue 7, 2016, Pages 1078-1084

  Lee, James A ^a   Roehrig, Charles S ^a   Butto, Erin Duggan ^a  

^a ALTARUM INSTITUTE   (United States)

Author keywords

cancer; cost of illness; health insurance; Healthcare Cost and Utilization Project; Medicaid; Medical Expenditure Panel Survey; medical expenditures; Medicare; out of pocket costs

Indexed keywords

ARTICLE; CANCER THERAPY; DRUG COST; HEALTH CARE COST; HEALTH CARE POLICY; HOME CARE; HOSPITALIZATION; HUMAN; MEDICAID; MEDICAL FEE; MEDICARE; NURSING HOME; OUTPATIENT CARE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; TREND STUDY; UNITED STATES; COST OF ILLNESS; ECONOMICS; FEMALE; MALE; NEOPLASM; TRENDS;

COST OF ILLNESS; FEMALE; HEALTH EXPENDITURES; HUMANS; MALE; NEOPLASMS; UNITED STATES;

EID: 84955497011     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29883     Document Type: Article

References (30)

1. DeSantis CE, Lin CC, Mariotto AB, et al., Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014; 64: 252-271.
2. National Cancer Institute, National Institutes of Health. SEER Cancer Statistics Review, 1975-2012. Available at: http://seer.cancer.gov/csr/1975-2012. Accessed August 26, 2015.
3. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML,. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011; 103: 117-128.
4. IMS Institute for Healthcare Informatics. Innovation in Cancer Care and Implications for Health Systems: Global Oncology Trend Report. Available at: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Corporate/IMS%20Health%20Institute/Reports/Secure/IMSH-Oncology-Trend-Report.pdf. Accessed July 23, 2015.
5. Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML,. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008; 100: 888-897.
6. Tangka FK, Trogdon JG, Richardson LC, Howard D, Sabatino SA, Finkelstein EA,. Cancer treatment cost in the United States: has the burden shifted over time? Cancer. 2010; 116: 3477-3484.
7. Conti RM, Fein AJ, Bhatta SS,. National trends in spending on and use of oral oncologics, first quarter 2006 though third quarter 2011. Health Aff. 2014; 33: 1721-1727.
8. Shih YCT, Smieliauskas F, Geynisman DM, Kelly RJ, Smith TJ,. Trends in the cost and use of targeted cancer therapies for the privately insured nonelderly: 2001 to 2011. J Clin Oncol. 2015; 33: 2190-2196.
9. Shih YCT, Ganz PA, Aberle D, et al., Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol. 2013; 31: 4151-4157.
10. Goldman DP, Philipson T,. Five myths about cancer care in America. Health Aff. 2014; 33: 1801-1804.
11. Ward E, Halpern M, Schrag N, et al., Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008; 58: 9-31.
12. Fedewa SA, Goodman M, Flanders WD, et al., Elimination of cost-sharing and receipt of screening for colorectal and breast cancer. Cancer. 2015; 121: 3272-3280.
13. Zafar SY, Peppercorn JM, Schrag D, et al., The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013; 18: 381-390.
14. Stockdale H, Guillory K,. Lifeline: Why Cancer Patients Rely on Medicare for Critical Coverage. American Cancer Society Cancer Action Network. Available at: https://www.acscan.org/content/wp-content/uploads/2013/06/2013-Medicare-Chartbook-Online-Version.pdf. Accessed August 20, 2015.
15. Meropol NJ, Schrag D, Smith TJ, et al., American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009; 27: 3868-3874.
16. Markman M, Luce R,. Impact of the cost of cancer treatment: an Internet-based survey. J Oncol Pract. 2010; 6: 69-73.
17. Bach PB,. Limits on Medicare's ability to control rising spending on cancer drugs. N Engl J Med. 2009; 360: 626-633
18. Roehrig C, Miller G, Lake C, Bryant J,. National health spending by medical condition. Health Aff. 2009; 28; 358-367.
19. Bernard D, Cowan C, Selden TM, Liming C, Catlin A, Heffler, S,. Reconciling medical expenditure estimates from the MEPS and NHEA, 2007. Medicare Medicaid Res Rev. 2012; 2: E1-E20.
20. Healthcare Cost and Utilization Project. Clinical Classifications Software (CCS) for ICD-9-CM. Available at: www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed August 31, 2015.
21. Healthcare Cost and Utilization Project. Overview of the National (Nationwide) Inpatient Sample (NIS), 2003. Available at: www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed August 31, 2015.
22. Maroongroge S, Kim SP, Mougalian S, et al., The cost of cancer-related physician services to Medicare. Yale J Biol Med. 2015; 88: 107-114.
23. Centers for Medicare and Medicaid Services. Medicare and Medicaid Statistical Supplement-2012 Edition. Table 13.4: Number of Medicaid Persons Served (Beneficiaries), by Eligibility Group: Fiscal Years 1975-2010. Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/MedicareMedicaidStatSupp/2012.html. Accessed August 6, 2015.
24. Mott DA, Thorpe JM, Thorpe CT, Kreling DH, Gadkari AS,. Effects of Medicare Part D on drug affordability and use: are seniors with prior high out-of-pocket drug spending affected more? Res Social Adm Pharm. 2010; 6: 90-99.
25. Trish E, Joyce G, Goldman DP,. Specialty drug spending trends among Medicare and Medicare Advantage enrollees, 2007-11. Health Aff. 2014; 33: 2018-2024.
26. Kaiser Family Foundation. Total Medicare Advantage Enrollment, 1992-2014. Available at: http://kff.org/medicare/slide/total-medicare-advantage-enrollment-1992-2014/. Accessed August 6, 2015.
27. Jacobson G, Damico A, Neuman T, Gold M,. Medicare Advantage 2015 Data Spotlight: Overview of Plan Changes. Available at: http://kff.org/medicare/issue-brief/medicare-advantage-2015-data-spotlight-overview-of-plan-changes/. Accessed August 6. 2015.
28. Centers for Medicare and Medicaid Services. Oncology Care Model. Available at: http://innovation.cms.gov/initiatives/oncology-care/. Accessed August 6, 2015.
29. Nass SJ, Patlak M,. Ensuring Patient Access to Affordable Cancer Drugs: Workshop Summary. Washington, DC: National Academies Press; 2014.
30. Avalere Health. An Analysis of Exchange Plan Benefits for Certain Medicines. Available at: http://www.phrma.org/sites/default/files/20140521-FINAL%20PhRMA-High%20Coinsurance%20and%20Tier%20Placement-Avalere%5B7a%5D-0.pdf. Accessed September 17, 2015.